ArticleThe oncologist2025

Efficacy of 2 different fibroblast growth factor receptor-inhibitors in a patient with extrahepatic cholangiocarcinoma harboring an FGFR2 mutation: a case report.

Ilianna Galli-Vareia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.